Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05592548 · ClinicalTrials.gov registry record · NA
Rosacea Treatment Using Non-thermal (Cold) Atmospheric Plasma Device
A NA study, sponsored by The Skin Center Dermatology Group.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT05592548: Completed NA study, sponsored by The Skin Center Dermatology Group.
NCT05592548 is a NA study that has completed, run by The Skin Center Dermatology Group. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05592548, a NA study, has completed, sponsored by The Skin Center Dermatology Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
10-13 patients will be enrolled to receive split face treatment: the control side will be treated with metronidazole cream, the intervention side will be treated with a cold atmospheric plasma device
Primary Outcome
Rosacea improvement will be evaluated based on clinical photos (worsened, unchanged, mild improvement, substantial improvement, cleared)
Interventions
- DEVICE cold atmospheric plasma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2024-01-02 |
| Est. Completion | 2024-06-30 |
| Phase | NA |
What the finished NCT05592548 record still lists
NCT05592548 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which cold atmospheric plasma is the first listed.
NCT05592548 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05592548 about?
NCT05592548 is a clinical study titled "Rosacea Treatment Using Non-thermal (Cold) Atmospheric Plasma Device". 10-13 patients will be enrolled to receive split face treatment: the control side will be treated with metronidazole cream, the intervention side will be treated with a cold atmospheric plasma device
What is the current status of trial NCT05592548?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2024-01-02. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT05592548?
The interventions under investigation include: cold atmospheric plasma (DEVICE).
Who is sponsoring clinical trial NCT05592548?
This trial is sponsored by The Skin Center Dermatology Group, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05592548's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI